PolyCrystalLine showcases Quality by Design PAT capabilities in new web presence
Press Release | PolyCrystalLine S.R.L.
APRIL 27, 2015
Bologna, Italy: – Specialist crystal form CRO PolyCrystalLine Srl. (PCL) has rolled out its new website allowing it to display more of its in depth Quality by Design expertise in process analytical technology (PAT).
The new site went live at http://www.polycrystalline.it earlier this month.
The new site design uses Flash, xml and other leading-edge web technologies to give a cutting edge look to the presentation of PCL’s capabilities and QbD PAT-related services such as Optimization of Crystallization & Synthesis and Scale Up capabilities.
Scale up expertise
Also featured on front page and in the News Gallery is PCL’s recently awarded Good Manufacturing Practice (GMP) status for chemical and physics analyses for qualitative and quantitative determination of active ingredients, intermediates and finished products derived from crystalline forms following a successful audit.
Specifically, the certification approves PolyCrystalLine’s use of X-ray powder diffraction, Fourier transform infrared (FTIR) spectroscopy and FT-Raman spectroscopy.
At the same time as raising its virtual presence, PolyCrystalLine has also ramped up its tangible manufacturing profile. Recent PCL improvement of its production facilities has included bringing a new 50 ft2 kilo lab on stream.
PCL has also signaled its intention to attend CPhI Worldwide 2015 in Madrid next October. The company is inviting anyone interested in meeting them at the show to contact PolyCrystalLine using the embedded link (See also Resources below).
PolyCrystalLine Srl has rapidly established prominence in research and characterization of crystal forms and solid-state compounds, particularly in the pharmaceutical field.
The company has its roots in academia, building on research and collaborative networks to form a business. Academic knowledge is combined with business skills, employing a close relationship with scientific methodology to construct original, forward-thinking approaches to solve technical, patenting and commercial problems.
PolyCrystalLine’s extensive experience in the characterization of solid-state compounds and the study of polymorphism has been leveraged into development of explicit and adaptable research protocols that can be adjusted to meet the requirements of the pharmaceutical industry. It investigates the thermal behaviour of pharmaceutical compounds through a wide range of methods including X-ray powder diffraction, calorimetric, thermogravimetric and evolved gas analysis.
The company is able to meet a diverse range of research needs and budget requirements, from comprehensive analysis of APIs and compounds/solvates to rapid low cost screening and studies that involve patent issues.
It can provide crystallization processes utilising modular approaches ranging from milligrams to half kilogram scale, along with expert knowledge in regards to the optimization of different parameters during the crystallization processes to achieve desired crystal forms, yields, particle size, etc.
PolyCrystalLine clients include AET, Bracco, Chemi, DeveloPharma, Dipharma, Novartis, Polpharma, Rivopharm and Zach System.
Dr. Stefano Luca Giaffreda, CEO, PolyCrystalLine s.r.l
Tel. +39 051 6970791
Click on PolyCrystalLine showcase quality by design capabilities in new web presence for more information.
Click on http://www.polycrystalline.it to explore the new PolyCrystalLine website.
Click on PolyCrystalLine to contact the company directly.